Evidence map›Paper›PMID 34547969›Full record

Observational studyRenal failure2021

Retrospective analysis of nontraumatic subdural hematoma incidence and outcomes in Egyptian patients with end-stage renal disease on hemodialysis.

Ahmed Fayed, Ayman Tarek, Mohamed I Refaat, Sameh Abouzeid, Sohail Abdul Salim, Lajos Zsom, Tibor Fülöp, Karim M Soliman, Mohamed A Elmallawany

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Renal failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Ahmed FayedNephrology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.ORCID 0000-0002-6041-4016
Ayman TarekNeurosurgery Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.
Mohamed I RefaatNeurosurgery Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.
Sameh AbouzeidNephrology Department, Theodor Bilharz Research Institute, Cairo, Egypt.
Sohail Abdul SalimDepartment of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, MS, USA.ORCID 0000-0001-7304-6307
Lajos ZsomFresenius Medical Care Hungary, Cegléd, Hungary.
Tibor FülöpDepartment of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, SC, USA.
Karim M SolimanDepartment of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, SC, USA.
Mohamed A ElmallawanyNeurosurgery Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.
Cairo University · EGMedical University of South Carolina · USTheodor Bilharz Research Institute · EGUniversity of Mississippi Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe incidence of subdural hematoma (SDH) in chronic maintenance hemodialysis (CMH) patients may change over time, along with the evolving characteristics of the underlying populations.

methodsWe conducted a retrospective, single-center study at Cairo University hospitals, assessing the incidence, associated risk factors, and outcomes of nontraumatic SDH in CMH patients between January 2006 and January 2019.

resultsOut of 1217 CMH patients, nontraumatic SDH was diagnosed in 41 (3.37%) during the study, increasing with the enrollees' age but stable over the observation period and translating into an annual incidence rate of 28 per 1000 patients per year. SDH patients were likely to use central venous catheters, reported pruritis and history of bone fractures, and had higher phosphorus, parathyroid hormone, and alkaline phosphatase values (

conclusionOur study demonstrated a striking enrichment for underlying comorbidities in those patients developing SDH and a high risk of immediate mortality. The benefit of chronic anticoagulation therapy should be carefully weighed against the risk of CNS bleed in MHD patients.

Indexed as

AgedAnticoagulantsAtrial FibrillationEgyptFemaleHematoma, SubduralHumansIncidenceKidney Failure, ChronicMaleMiddle AgedRenal DialysisRetrospective StudiesRisk FactorsAnticoagulantsHemodialysismortalitynontraumatic subdural hematomaoutcome

Identifiers

PMID34547969
PMCPMC8462880
OpenAlexW3200818542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.